Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease
1. In patients with Crohn’s disease (CD), fecal calprotectin (FC) was a useful biomarker for monitoring small bowel lesions and ...
Tag: Gastroenterology
Time-restricted eating does not confer changes in sleep, mood, or quality of life
1. Time-restricted eating, regardless of timing of the eating window, did not result in significant changes in sleep, mood, or ...
2 Minute Medicine Rewind June 30, 2025
Right C7 neurotomy at the intervertebral foramen plus intensive speech and language therapy versus intensive speech and language therapy alone ...
2 Minute Medicine Rewind June 23, 2025
Weighted Vest Use or Resistance Exercise to Offset Weight Loss–Associated Bone Loss in Older Adults: A Randomized Clinical Trial 1. ...
Rectoscopy alone may be sufficient to evaluate for remission of ulcerative colitis
1. Rectoscopy alone for evaluation of endoscopic and histologic remission of ulcerative colitis (UC) had good accuracy and is sufficient ...
Both intestinal ultrasound and magnetic resonance imaging can assess radiologic stricturing in Crohn’s disease
1. Intestinal ultrasound (IUS) and magnetic resonance imaging (MRI) were effective imaging modalities for the assessment of the radiologic response ...
Probiotic mitigates gut hypoperfusion-associated acute gastrointestinal injury in patients undergoing cardiopulmonary bypass
1. In this randomized controlled trial, preoperative probiotic supplementation was associated with a reduced incidence of acute gastrointestinal injury (AGI) ...
2 Minute Medicine Rewind April 28, 2025
Alcohol Use Disorder Diagnoses Among Individuals Who Take HIV Preexposure Prophylaxis 1. In this cohort of individuals taking preexposure prophylaxis ...
Heterogeneous treatment effects of stress ulcer prophylaxis among ICU patients at risk for gastrointestinal bleeding
1. In patients admitted to the intensive care unit (ICU) with at least one risk factor for clinically significant gastrointestinal ...
Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer
1. While not statistically significant, the use of sotorasib plus panitumumab may have a 30% relative risk reduction in the ...
